Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Adhesive Seals Blood Vessels

14.05.2009
Due to inflammations, blood vessels may become leaky: Blood plasma leaks into the tissue which might involve serious complications. Researchers from the University of Würzburg have now developed a kind of molecular adhesive sealing hyperpermeable blood vessels.

Inside, blood vessels are lined with a single layer of cells. On their surface, these cells bear specific adhesive proteins by means of which they stick close to each other. Normally, this ensures a perfect sealing of the blood vessels.

The most important adhesive protein is the so-called VE-cadherin. It can be destabilized due to different pathological conditions, e.g. due to a sepsis when bacteria have penetrated into the bloodstream and spread within the whole body. This infection causes inflammatory processes which involve leaks in the blood vessel lining. Blood plasma leaks which might result in life-threatening organ swellings as well as tissue bleeding.

To date, there is no means to seal hyperpermeable blood vessels. However, this would be very helpful e.g. for treating patients with pulmonary edema or allergy-induced organ swelling.

Small peptides ensure adhesion

Here, researchers from the "Institut für Anatomie und Zellbiologie" (Institute of Anatomy and Cell Biology) of the University of Würzburg succeeded in taking a first step forward: They have developed small peptide molecules which increase adhesion between vital VE-cadherin adhesive proteins. Thus, the vascular lining is stabilized against inflammatory stimuli.

How do the peptide molecules work? They work just like an adhesive: They bridge the adhesive proteins with each other, because they are designed following the example of the structure by means of which the VE-cadherins stick close to each other. They have a crosslinking effect which they deploy as tandem peptides arranged one after the other - similar to a medical strip with two adhesive ends.

Still far away from application in humans

"These results offer new approaches for the treatment of vascular hyperpermeability", says Prof. Detlev Drenckhahn. However, it is still a long way to go until an application in humans is possible, because the current structure of the molecules is not suitable for such an application.

According to Prof. Drenckhahn it is always difficult to apply peptides to humans, because an unexpected immune response is possible. The next step for the researchers from Würzburg now is to find other molecules resembling the peptides in structure and effect.

Publication in the Journal of Cell Science

The leading researchers from Würzburg Wolfgang-Moritz Heupel, Jens Waschke and Detlev Drenckhahn describe their new approach in the current issue of the Journal of Cell Science. They have worked together with the structural biologist Thomas Müller from the Biocenter who has developed the peptide molecules on the computer. The peptide molecules have been tested in different systems together with the chemist Athina Hübner, the medical scientist Nicolas Schlegel and other employees of the "Institut für Anatomie und Zellbiologie" (Institute of Anatomy and Cell Biology).

The efficiency of the novel molecules could be shown for isolated VE-cadherin adhesive proteins as well as in vivo by means of atomic force microscopy (AFM): If the protective "adhesive" is injected into the blood vessels of mice, their vascular lining does not break down when being exposed to an experimentally generated inflammatory stimulus.

"Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo", Wolfgang-Moritz Heupel, Athina Efthymiadis, Nicolas Schlegel, Thomas Müller, Yvonne Baumer, Werner Baumgartner, Detlev Drenckhahn, Jens Waschke; J Cell Sci. 2009 May 15;122(Pt 10):1616-1625, doi: 10.1242/jcs.040212

Further information

Prof. Dr. Detlev Drenckhahn, "Institut für Anatomie und Zellbiologie", University of Würzburg, phone: +49 (0)931 31-2702, drenckhahn@uni-wuerzburg.de

Robert Emmerich | idw
Further information:
http://www.uni-wuerzburg.de

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>